Good MorningThe tug of war between the bulls and bears continued on Wednesday leaving the broad market S&P 500 lower for the session. The Dow Jones Industrial Average closed with a smaller loss but the real story is about Tech and Transports. On the one hand, shares of tech heavyweight remain under pressure keeping the NASDAQ Composite behind its peers and down 2.0%. On the other hand, the Dow Jones Transportation Average gained nearly 2.0% at its high to close just shy of another new all-time high.
One reason for the dislocation in trading is rising interest rates. Rising interest rates make growth more costly for the tech sector and that will cut into their earnings. This situation makes the transports and other dividend-paying blue chips more attractive than ever before but the real test for the markets will be on Friday, however, with the release of core consumer inflation data.
Featured: The 7 Stocks Quietly Gaining Attention Right Now (Ad) 
|
Industrials | |
Steelcase Is Why Stock Picking Matters
We don’t want to single out Steelcase (NYSE:SCS) as a bad investment because it’s not. What it is is a uniquely positioned company within a very good industry. While furniture company’s like At Home Group (NYSE: HOME) and Haverty have seen... Read the Full Story |
|
From Our Partners | | Matt Monaco started with a $2,000 trading account and no clear strategy. After two years of trial and error, he crossed $1 million in 2020.
Today his account sits at $3 million, generating roughly $100,000 a month using a repeatable system he calls The Income Blueprint.
He's revealing the exact five-step scan and three trading lanes behind it in a free live training. | | Reserve your seat and claim The Income Blueprint free |
|
Healthcare | |
Cannabis producer Canopy Growth Corporation (NASDAQ: CGC) stock lost half its value from its 2021 highs during the March Nasdaq correction. Shares are attempting to rebound as marijuana legalization and decriminalization tailwinds continue to accelerate as evidenced by New York is edging closer to... Read the Full Story |
|
Communication Services | | Similar to how stocks that are related to cryptocurrency, cannabis, and electric vehicles rallied on heavy volume a few months back, we are witnessing new speculative trading activity in companies that are involved in the non-fungible token (NFT) space. If you aren’t familiar with NFTs, they a... Read the Full Story |
|
From Our Partners | | A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years.
While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million.
One company controls the entire supply chain behind this discovery. | | See the ticker behind this Grand Canyon energy breakthrough now |
|
Healthcare | | When multiple analysts have a favorable opinion on a stock it can be an overwhelming buy signal. Although it doesn't mean the investment doesn't have its risk factors, a green light from an army of Wall Street firms generally means the company has a very bright outlook.
It won't come as a surprise ... Read the Full Story |
|
Industrials | |
Shares of Blink Charging (NASDAQ:BLNK) are down sharply in advance of the company’s earnings report. Is this an example of investors preparing for good news, or is it a sell-off in advance of a disappointing report?
At this point, I’m going to say it really doesn’t matter. Blink... Read the Full Story |
|
From Our Partners | | A small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares still trade under 1 dollar.
It just signed the largest transaction in its history, a new gold streaming deal backed by a strategic relationship with a major mining investment firm.
A well-known sector financier has invested his own money and joins the CEO in an exclusive interview breaking down the full story. | | Click here for instant access to the free report now |
|
Technology | | Shares of software giant Adobe (NASDAQ: ADBE) found themselves down slightly in yesterday’s session despite posting solid earnings on Tuesday evening. They’d been trading fairly sideways since the last quarter of 2020 but had been starting to trend down this month as the cyclical rotatio... Read the Full Story |
|
Consumer Discretionary | |
Shoe Carnival Is No House Of Horrors For Investors
Shoe Carnival (NASDAQ: SCVL) is one of those underappreciated pandemic winners that just keeps on delivering. The company’s efforts in eCommerce and safe store operations have driven the company to great success and have it on track for Y... Read the Full Story |
|
Consumer Discretionary | | Best Buy (NYSE: BBY) is a little like the character from “Monty Python and the Holy Grail,” who shouts, “Not dead yet” as undertakers try to cart him away.
It was less than a decade ago that the big-box electronics retailer seemed to be on its last legs, losing customers to... Read the Full Story |
|
Technology | |
Solar energy solutions provider First Solar (NASDAQ: FSLR) stock saw a parabolic spike heading into 2021 thanks to the clean and renewable energy and environmental, sustainable and governance (ESG) investment themed momentum driven by the global decarbonization initiatives adopted by the Biden Adm... Read the Full Story |
|
Finance | | Every once in a while, a company like Upstart Holdings (NASDAQ:UPST) comes along and completely catches the market off-guard with an unexpectedly strong earnings report. This can result in institutional investors acquiring shares at a rapid rate and driving the share price up quickly. This is most l... Read the Full Story |
|
The Early Bird Stock Of The Day Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing BP1001-A that is in Phase I clinical trial for the treatment of solid tumors; Liposomal Bcl-2 (BP1002), which is in Phase I clinical trial for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; and Liposomal STAT3 (BP1003) for treating pancreatic cancer, non-small cell lung cancer, and AML. The company was founded in 2007 and is based in Bellaire, Texas. | | View Today's Stock Pick |
|
